Back to search results

Observational Study on Stage IV Melanoma Clinical Trial Participation

This is an observational study looking at how people with stage IV melanoma (a type of skin cancer that has spread) participate in clinical trials. It's not testing a new treatment, but rather observing patterns of enrollment and how long people stay in trials. The study aims to understand why some patients join trials and why others might leave early. To join, you must be at least 18 years old, have stage IV melanoma, and be able to understand and agree to the study. Women who are pregnant or nursing, or people with certain psychiatric or substance abuse disorders, cannot participate. The study will track how many patients enroll in other clinical research over 3 months and how many stay in those trials for 12 months.

Study design
This is an observational study, meaning it will watch and collect information without giving any specific intervention. It plans to include about 500 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will look at participation patterns over 3 months and trial completion rates over 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06093594

Investigating Participation Patterns Among Stage IV Melanoma Patients

Not Yet Recruiting
Not specifiedAges 18+Observational
Power Life Sciences Inc.
~500 participants
Updated 2023-10-23 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of stage IV melanoma patients who decide to enroll in a clinical research
Measured over 3 months
+1 more outcome measured

Conditions

Stage IV Melanoma

Explore related trials

Melanoma

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.

Who to contact

Michael B Gill
[email protected]
415-900-4227
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Aged ≥ 18 years old
Diagnosis of stage IV melanoma
Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion

Female patients who are currently pregnant or nursing
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Inability to perform regular electronic reporting

What this trial measures

  • Number of stage IV melanoma patients who decide to enroll in a clinical research3 months
  • Rate of stage IV melanoma patients who remain in clinical trial to trial completion12 months